Navigation Links
2.5xx SheerVision Ultra-Light Loupes - SV Sport Frame

Products2.5xx SheerVision Ultra-Light Loupes - SV Sport Frame
Company SheerVision
Item 2.5xx SheerVision Ultra-Light Loupes - SV Sport Frame
Features 
  • Sharp, edge-to-edge clarity
  • High resolution optics
  • Lightweight design
  • Multi-coated for: anti-glare, anti-fog and scratch-resistance
  • Manufacturer direct pricing - save up to 40% off the competition
  • 30 day trial period
  • 100% satisfaction guaranteed
Description Experience the finest surgical-quality loupes available at manufacturer-direct prices. We set the standard for innovative optical design, combining superior quality withunmatched customer support. Delivering optimum performance with maximum comfort, SheerVision loupes are the clear choice for medical professionals worldwide. Make both a professional and a fashion statement by wearing the SV Sports Frame. The SV Sport Frame is available in eight vibrant colors and is designed so that prescription lenses can be added.
Info SheerVision
Customer Service: (877) 678-4274

Related medicine products :

1. SheerVision Surgical Magnifying Loupes
2. SheerVision FireFly LED Light System
3. FireFly LED Light System & SheerVision 2.5x Titanium-Frame Loupe Package
4. 3.0xx SheerVision Ultra-Light TTL Loupes - Titanium Frame
5. 3.0xx SheerVision Ultra-Light TTL Loupes - SV Sport Frame
6. 3.0x SheerVision Loupes - Titanium Frame
7. 3.0xx SheerVision Ultra-Light Loupes - SV Sport Frame
8. 3.0x SheerVision Loupes - SV Sport Frame
9. 3.5x SheerVision Loupes - SV Sport Frame
10. 3.0xx SheerVision Ultra-Light Loupes - Titanium Frame
11. 3.5x SheerVision Loupes - Titanium Frame
Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3DecisionView Launches StudyOptimizer(TM) 4 2DecisionView Launches StudyOptimizer(TM) 4 3Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3NASA Research Reveals Major Insight Into Evolution of Life on Earth 4870 1NASA Research Reveals Major Insight Into Evolution of Life on Earth 4870 2The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 54897 1The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 54897 2The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 54897 3The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 54897 4Patch Shots May Someday Replace Injections 54893 1Patch Shots May Someday Replace Injections 54893 2